Aster DM Healthcare Limited (ASTERDM.NS)
INR 492.7
(-0.46%)
INR 492.7
(-0.46%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -508.89 Million | 18.33 Billion | 13.13 Billion | 15.69 Billion | 12.23 Billion | 5.83 Billion |
| Net Income | 1.22 Billion | 5.35 Billion | 6.36 Billion | 2.05 Billion | 3.49 Billion | 4.12 Billion |
| Depreciation & Amortization | 2.19 Billion | 7.8 Billion | 6.4 Billion | 6.17 Billion | 5.85 Billion | 3.06 Billion |
| Deferred income taxes | - | 1.03 Billion | 1.84 Billion | 2.58 Billion | 1.09 Billion | 1.32 Billion |
| Stock-based compensation | 73.6 Million | 6.7 Million | -1.3 Million | 24.9 Million | 11.9 Million | 31.9 Million |
| Change in working capital | -16.71 Billion | 878.9 Million | -4.02 Billion | 1.95 Billion | -1.77 Billion | -4.39 Billion |
| Other non-cash items | 22.42 Billion | 3.26 Billion | 2.54 Billion | 2.89 Billion | 3.53 Billion | 1.68 Billion |
| Investing Cash Flow | -9.3 Billion | -9.71 Billion | -5.7 Billion | -3.3 Billion | -6.67 Billion | -6.91 Billion |
| Investments in PPE | -8.05 Billion | -8.48 Billion | -5.47 Billion | -4.23 Billion | -5.3 Billion | -5.77 Billion |
| Acquisitions | 19.19 Million | -1.3 Billion | -472.6 Million | 654.1 Million | -2.33 Billion | -1.85 Billion |
| Investment purchases | -1.35 Billion | -46.1 Million | 297.7 Million | -125.3 Million | -91.7 Million | 101.9 Million |
| Sales/Maturities of investments | 82.1 Million | 1.35 Billion | 174.9 Million | -528.8 Million | 203.1 Million | 223.6 Million |
| Other Investing Activities | -877.4 Million | -1.24 Billion | -225.1 Million | 933.5 Million | 856.8 Million | 387.6 Million |
| Financing Cash Flow | 13.07 Billion | -8.17 Billion | -6.85 Billion | -11.16 Billion | -6.74 Billion | 1.34 Billion |
| Debt repayment | -18.06 Billion | -6.01 Billion | -3.66 Billion | -5.55 Billion | -723.5 Million | -2.92 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.2 Billion | - |
| Common Stock Issuance | - | - | 5.8 Million | 7.9 Million | 10.4 Million | 24.3 Million |
| Other Financing Activities | -179.2 Million | -2.15 Billion | -3.19 Billion | -5.61 Billion | -4.11 Billion | 4.24 Billion |
| Accounts receivables | -2.21 Billion | -3.18 Billion | -1.82 Billion | 359.5 Million | -3.26 Billion | -5.55 Billion |
| Accounts payables | 5.52 Billion | 7.77 Billion | - | - | - | 5.55 Billion |
| Inventory | -3.03 Billion | -1.92 Billion | -1.44 Billion | 945.7 Million | -1.48 Billion | -633.8 Million |
| Other working capital | -11.46 Billion | -1.77 Billion | -754.4 Million | 652.7 Million | 2.97 Billion | -3.76 Billion |
| Cash at beginning of period | 4.21 Billion | 2.99 Billion | 2.34 Billion | 1.14 Billion | 2.24 Billion | 1.91 Billion |
| Cash at end of period | 1.12 Billion | 3.65 Billion | 2.99 Billion | 2.34 Billion | 1.14 Billion | 2.24 Billion |
| Capital Expenditure | -8.05 Billion | -8.48 Billion | -5.47 Billion | -4.23 Billion | -5.3 Billion | -5.77 Billion |
| Effect of forex changes on cash | 64 Million | 210.3 Million | 72.2 Million | -27.9 Million | 89.1 Million | 65 Million |
| Net cash flow / Change in cash | -3.09 Billion | 657.4 Million | 647.8 Million | 1.19 Billion | -1.09 Billion | 329.3 Million |
| Free Cash Flow | -8.56 Billion | 9.85 Billion | 7.65 Billion | 11.45 Billion | 6.92 Billion | 57 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 51.45 Billion | 1.22 Billion | -240.3 Million | 1.79 Billion | -307.9 Million | 49 Million |
| Depreciation & Amortization | - | 2.19 Billion | - | 2.31 Billion | 2.27 Billion | 2.17 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 73.6 Million | - | - | - | - |
| Change in working capital | - | -16.71 Billion | - | - | - | - |
| Other non-cash items | -51.45 Billion | 22.42 Billion | 240.3 Million | -1.79 Billion | 307.9 Million | -49 Million |
| Investing Cash Flow | - | -9.3 Billion | - | - | - | - |
| Investments in PPE | - | -8.05 Billion | - | - | - | - |
| Acquisitions | - | 19.19 Million | - | - | - | - |
| Investment purchases | - | -1.35 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 82.1 Million | - | - | - | - |
| Other Investing Activities | - | -877.4 Million | - | - | - | - |
| Financing Cash Flow | - | 13.07 Billion | - | - | - | - |
| Debt repayment | - | -18.06 Billion | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -179.2 Million | - | - | - | - |
| Accounts receivables | - | -2.21 Billion | - | - | - | - |
| Accounts payables | - | 5.52 Billion | - | - | - | - |
| Inventory | - | -3.03 Billion | - | - | - | - |
| Other working capital | - | -11.46 Billion | - | - | - | - |
| Cash at beginning of period | - | 4.21 Billion | - | 4.59 Billion | 48.6 Million | 4.21 Billion |
| Cash at end of period | - | 1.12 Billion | - | 9.22 Billion | 4.59 Billion | 8.56 Billion |
| Capital Expenditure | - | -8.05 Billion | - | - | - | - |
| Effect of forex changes on cash | - | 64 Million | - | - | - | - |
| Net cash flow / Change in cash | - | -3.09 Billion | - | 4.63 Billion | 4.54 Billion | 4.34 Billion |
| Free Cash Flow | - | -8.56 Billion | - | 4.63 Billion | 4.54 Billion | 4.34 Billion |
NET
AAVAS
2736
3341
EVGRU
WM